These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3509450)

  • 1. Cefotetan in the treatment of internal medicine infections in diabetic patients.
    Romanelli G; Agabiti-Rosei E; Muiesan M; Pellizzari G; Lanzini A; Guarnera L; Muiesan G
    Chemioterapia; 1987 Jun; 6(2 Suppl):375-7. PubMed ID: 3509450
    [No Abstract]   [Full Text] [Related]  

  • 2. Infectious complications in diabetic patients.
    File TM; Tan JS
    Curr Ther Endocrinol Metab; 1994; 5():452-7. PubMed ID: 7704772
    [No Abstract]   [Full Text] [Related]  

  • 3. Cefotetan in the treatment of post-operative infections following obstetric and gynecological surgery.
    Cianci A; Pafumi C; Tempera G; Toscano M; Corbino N; Palumbo G
    Chemioterapia; 1987 Jun; 6(2 Suppl):537-8. PubMed ID: 3509493
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of urinary tract infections in elderly diabetic patients with cefotetan.
    Romanelli G; Giustina A; Cravarezza P; Zuccato F; Ravizzola G; Turano A
    J Chemother; 1989 Jul; 1(4 Suppl):1013-4. PubMed ID: 16312749
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience with rational cefotetan therapy in in situ and associated surgical infections].
    Puleo S; Li Destri G; Scuderi M; Sammartino R; Romeo MA; Gismondo MR; Nicoletti G
    Ann Ist Super Sanita; 1987; 23(4):911-3. PubMed ID: 3482980
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cefotetan: clinical trial in elderly persons using a single daily dose of 2 grams as the sole therapy].
    Gaillat J; Croize J; Bru JP; Stahl JP; Le Noc P; Micoud M
    Pathol Biol (Paris); 1986 May; 34(5):461-4. PubMed ID: 3534722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious complications in diabetic patients.
    File TM; Tan JS
    Curr Ther Endocrinol Metab; 1997; 6():491-5. PubMed ID: 9174794
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cefotetan vs ceftriaxone: clinical and bacteriological efficacy in complicated forms of urinary tract infection].
    D'Amato C; De Carli G; Leoni GC; Bordi E; Carvelli C; Colaiacomo M; Struglia C; Visco G
    Clin Ter; 1989 Mar; 128(5):347-50. PubMed ID: 2524322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of rifamycin SV in ampules of 250 and 500 mg produced by the Tarchomin Pharmaceutical Plants "Polfa"].
    Hanzlik J; Wojnicz A; Wolański I; Grzywnowicz J
    Ann Univ Mariae Curie Sklodowska Med; 1986; 41():31-40. PubMed ID: 3154057
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cefotetan treatment of suppurative bronchopulmonary syndromes sustained by anaerobic germs].
    Caputi M; Guarino C; Cautiero V; Sorrentino L; Cione P; Cuccurullo S; Tarantino C
    Arch Monaldi Mal Torace; 1990; 45(5):401-10. PubMed ID: 2152338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical trials of the ampicillin-dicloxacillin combination].
    Filorizzo G; De Giorgio L
    Minerva Med; 1974 May; 65(38-39):2241-7. PubMed ID: 4422453
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical studies of the therapeutic activity of an association of dicloxacillin and hetacillin].
    Giannelli F; Cattaneo E
    Minerva Med; 1973 Nov; 64(82):4354-66. PubMed ID: 4765439
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical and pharmacokinetic study of cefotetan in biliary tract infections: preliminary report.
    Cristiano P; Lobello R; Iovene MR; De Ascentis G; Altucci P; Paradisi F; Manguso L
    Chemioterapia; 1988 Aug; 7(4):233-6. PubMed ID: 3180302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftazidime: therapeutic results in various infections.
    Sakellariou G; Alexopoulos E; Natshe T; Hadjidimitriou C; Kalpakoglou S; Karayiannis A; Papadimitriou M
    Chemioterapia; 1987 Jun; 6(2 Suppl):373-4. PubMed ID: 3334579
    [No Abstract]   [Full Text] [Related]  

  • 15. Infectious complications in diabetic patients.
    Murphy DP; Tan JS; File TM
    Prim Care; 1981 Dec; 8(4):695-714. PubMed ID: 6915591
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic efficacy of cefalexin in internal medicine].
    Lechi A; Cecchetin M
    Clin Ter; 1972 Mar; 60(5):439-47. PubMed ID: 5038776
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of the antibiotic association of dicloxacillin and hetacillin (Dicloeta)].
    Frajese G; Falaschi P
    Minerva Med; 1973 Nov; 64(82):4349-53. PubMed ID: 4797268
    [No Abstract]   [Full Text] [Related]  

  • 18. Is an initial small-spectrum antibiotic regimen safe in fulminant hepatic failure?
    Clemmesen J; Larsen F; Rasmussen A; Hansen B
    Transplant Proc; 1995 Dec; 27(6):3505. PubMed ID: 8540071
    [No Abstract]   [Full Text] [Related]  

  • 19. [The treatment of bacterial respiratory and urinary tract infections with cefazedone. Clinical proof of effectiveness and tolerance].
    Schneiderhan H; Buchegger G
    Fortschr Med; 1981 Mar; 99(12):435-8. PubMed ID: 7227942
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multicenter research on the clinical effectiveness and tolerability of an antibacterial drug. Results of 1063 cases].
    Privitera G; Bonino S; Del Mastro S
    Clin Ter; 1982 Apr; 101(2):123-36. PubMed ID: 7094544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.